Pancreas
Gut. 2024;73(4):629–38
Revisiting the performance of cyst fluid carcinoembryonic antigen as a diagnostic marker for pancreatic mucinous cysts: A comprehensive 20-year institutional review
Objective: Elevated pancreatic cyst fluid carcinoembryonic antigen (CEA) has been routinely used to classify mucinous cysts. This study incorporates original data that established the CEA ≥ 192 ng/ml threshold with over 20 years of additional data and re-assesses the diagnostic performance of CEA for differentiating mucinous from non-mucinous cysts.
Design: 1169 pancreatic cysts (1999–2021) with CEA results were identified. 394 cases had histological confirmation as the diagnostic standard. Additionally, 237 cysts without histological confirmation demonstrated KRAS, GNAS, or RNF43 mutations by molecular testing and were combined with the histologically confirmed cysts for separate analysis on a total cohort of 631 cysts.
Results: Median CEA was significantly higher in mucinous cysts (323.9 ng/ml, n = 314) versus non-mucinous cysts (204.6 ng/ml, n = 80) (p < 0.001). Receiver-operating characteristic curve analysis demonstrated an optimal CEA cut-off of 20 ng/ml (area under the curve, 80%), though the specificity was lower than desired (sensitivity 89%, specificity 64%). At the previously established threshold of 192 ng/ml, sensitivity and specificity were 56% and 78%, respectively. To achieve a specificity of 85% as originally reported, a CEA threshold of 250 ng/ml was needed; the 13 false-positive cases at this threshold included 4 benign simple cysts, 2 squamoid cysts, 1 serous cystadenoma, 1 lymphoepithelial cyst and 5 more uncommon entities. All results remained similar within the total cohort after including additional cases with KRAS/GNAS/RNF43 mutations only.
Conclusion: Cyst fluid carcinoembryonic antigen (CEA) continues to be a useful test in the diagnosis of mucinous pancreatic cysts but does not appear as specific as previously reported. Raising the CEA threshold to 250 ng/ml to maintain specificity for differentiating mucinous from non-mucinous cysts may be considered.